ConductScience.org, home

Gene · 7012

NIH grants2,639

NIH grants whose papers are about the gene, through NIH's grant-paper links.

101 to 120 of 2,639

Download this page as JSON
GrantTitleTERC papersNewest fiscal year
P50CA127001SPORE in Brain Cancer22025
R01AG016642Mechanism of the telomeric proliferation limit22025
R01CA178441Combinatorial epigenetic-based prevention of breast cancer22025
R01CA188228Evolution of gliomas during treatment and resistance22025
R01DK062794The role of the innate immune cell cyclooxygenase/prostaglandin system in blood pressureregulation22025
R01DK095785Role of the innate immune system in acute kidney injury22025
R01HL151651Functional and molecular consequences of SF3B1 mutations in human hematopoietic stem cells22025
R01MH101244Functional and population genetic architectures of complex disease22025
R24AG048024Advancing Psychosocial and Biobehavioral Stress Measurement and Interventions to Promote Healthy Aging22025
R25ES025476Colorado Undergraduate Research in Environmental Health Sciences22025
R35CA197568Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery22025
R35CA210036Genome instability in cancer: telomeres and DNA repair22025
R35GM131901Structural biology of telomerase and telomeres22025
T32AG000243Specialized Training: Demography and Economics of Aging - Renewal 01 - Renewal22025
T32AG000255Training in age related neurodegenerative diseases22025
T32CA009216Molecular Immunology and Tumor Biology22025
T32CA009476Cancer Biology Training Program22025
T32HG002295Training in Bioinformatics and Integrative Genomics22025
T32HL007093Hematology Training22025
T32HL007439Hematology Clinical Research Training Program22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/7012/grants?page=6